Monique M Gardner1, Matthew P Kirschen2, Hector R Wong3, Daniel J McKeone4, E Scott Halstead5, Jill M Thompson2, Adam S Himebauch2, Alexis A Topjian2, Nadir Yehya6. 1. Division of Cardiac Critical Care Medicine, Department of Anesthesiology & Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 2. Division of Critical Care Medicine, Department of Anesthesiology & Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 3. Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 4. Division of Pediatric Hematology and Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA, USA. 5. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA, USA. 6. Division of Critical Care Medicine, Department of Anesthesiology & Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Leonard Davis Institute, University of Pennsylvania, Philadelphia, PA, USA.
Abstract
AIMS: To identify plasma biomarkers associated with cardiac arrest in a cohort of children with acute respiratory distress syndrome (ARDS), and to assess the association of these biomarkers with mortality in children with cardiac arrest and ARDS (ARDS + CA). METHODS: This was a secondary analysis of a single-center prospective cohort study of children with ARDS from 2014-2019 with 17 biomarkers measured. Clinical characteristics and biomarkers were compared between subjects with ARDS + CA and ARDS with univariate analysis. In a sub-cohort of ARDS + CA subjects, the association between biomarker levels and mortality was tested using univariate and bivariate logistic regression. RESULTS: Biomarkers were measured in 333 subjects: 301 with ARDS (median age 5.3 years, 55.5% male) and 32 ARDS + CA (median age 8 years, 53.1% male). More arrests (69%) occurred out-of-hospital with a median CPR duration of 11 (IQR 5.5, 25) minutes. ARDS severity, PRISM III score, vasoactive-ionotropic score and extrapulmonary organ failures were worse in the ARDS + CA versus ARDS group. Eight biomarkers were elevated in the ARDS + CA versus ARDS cohort: sRAGE, nucleosomes, SP-D, CCL22, IL-6, HSP70, IL-8, and MIP-1b. sRAGE, SP-D, and CCL22 remained elevated when the cohorts were matched for illness severity. When controlling for severity of ARDS and cardiac arrest characteristics, sRAGE, IL-6 and granzyme B were associated with mortality in the ARDS + CA group. CONCLUSION: sRAGE, IL-6 and granzyme B were associated with cardiac arrest mortality when controlling for illness severity. sRAGE was consistently higher in the ARDS + CA cohort compared to ARDS and retained independent association with mortality.
AIMS: To identify plasma biomarkers associated with cardiac arrest in a cohort of children with acute respiratory distress syndrome (ARDS), and to assess the association of these biomarkers with mortality in children with cardiac arrest and ARDS (ARDS + CA). METHODS: This was a secondary analysis of a single-center prospective cohort study of children with ARDS from 2014-2019 with 17 biomarkers measured. Clinical characteristics and biomarkers were compared between subjects with ARDS + CA and ARDS with univariate analysis. In a sub-cohort of ARDS + CA subjects, the association between biomarker levels and mortality was tested using univariate and bivariate logistic regression. RESULTS: Biomarkers were measured in 333 subjects: 301 with ARDS (median age 5.3 years, 55.5% male) and 32 ARDS + CA (median age 8 years, 53.1% male). More arrests (69%) occurred out-of-hospital with a median CPR duration of 11 (IQR 5.5, 25) minutes. ARDS severity, PRISM III score, vasoactive-ionotropic score and extrapulmonary organ failures were worse in the ARDS + CA versus ARDS group. Eight biomarkers were elevated in the ARDS + CA versus ARDS cohort: sRAGE, nucleosomes, SP-D, CCL22, IL-6, HSP70, IL-8, and MIP-1b. sRAGE, SP-D, and CCL22 remained elevated when the cohorts were matched for illness severity. When controlling for severity of ARDS and cardiac arrest characteristics, sRAGE, IL-6 and granzyme B were associated with mortality in the ARDS + CA group. CONCLUSION: sRAGE, IL-6 and granzyme B were associated with cardiac arrest mortality when controlling for illness severity. sRAGE was consistently higher in the ARDS + CA cohort compared to ARDS and retained independent association with mortality.
Authors: John Bro-Jeppesen; Pär I Johansson; Jesper Kjaergaard; Michael Wanscher; Sisse R Ostrowski; Mette Bjerre; Christian Hassager Journal: Resuscitation Date: 2017-09-23 Impact factor: 5.262
Authors: Alexis A Topjian; Allan de Caen; Mark S Wainwright; Benjamin S Abella; Nicholas S Abend; Dianne L Atkins; Melania M Bembea; Ericka L Fink; Anne-Marie Guerguerian; Sarah E Haskell; J Hope Kilgannon; Javier J Lasa; Mary Fran Hazinski Journal: Circulation Date: 2019-06-27 Impact factor: 29.690
Authors: Jane E Whitney; Rui Feng; Natalka Koterba; Fang Chen; Jenny Bush; Kathryn Graham; Simon F Lacey; Jan Joseph Melenhorst; Samir M Parikh; Scott L Weiss; Nadir Yehya Journal: Crit Care Explor Date: 2020-12-04
Authors: José R Fioretto; Joelma G Martin; Cilmery S Kurokawa; Mário F Carpi; Rossano C Bonatto; Sandra M Q Ricchetti; Marcos A de Moraes; Carlos R Padovani Journal: Cytokine Date: 2008-06-18 Impact factor: 3.861
Authors: Maykel A Arias; María P Jiménez de Bagües; Nacho Aguiló; Sebastián Menao; Sandra Hervás-Stubbs; Alba de Martino; Ana Alcaraz; Markus M Simon; Christopher J Froelich; Julián Pardo Journal: Cell Rep Date: 2014-07-10 Impact factor: 9.423
Authors: Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch Journal: Pediatr Crit Care Med Date: 2010-03 Impact factor: 3.624
Authors: Martin Abild Stengaard Meyer; Sebastian Wiberg; Johannes Grand; Anna Sina Pettersson Meyer; Laust Emil Roelsgaard Obling; Martin Frydland; Jakob Hartvig Thomsen; Jakob Josiassen; Jacob Eifer Møller; Jesper Kjaergaard; Christian Hassager Journal: Circulation Date: 2021-03-22 Impact factor: 29.690